Cargando…
Calcilytic NPS 2143 Reduces Amyloid Secretion and Increases sAβPPα Release from PSEN1 Mutant iPSC-Derived Neurons
Despite numerous efforts and studies over the last three decades, Alzheimer’s disease (AD) remains a disorder not fully understood and incurable so far. Development of induced pluripotent stem cell (iPSC) technology to obtain terminally differentiated neurons from adult somatic cells revolutionized...
Autores principales: | Lo Giudice, Maria, Mihalik, Balázs, Turi, Zsófia, Dinnyés, András, Kobolák, Julianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918902/ https://www.ncbi.nlm.nih.gov/pubmed/31640098 http://dx.doi.org/10.3233/JAD-190602 |
Ejemplares similares
-
Synthesis of the calcilytic ligand NPS 2143
por: Johansson, Henrik, et al.
Publicado: (2013) -
The Nervous System Relevance of the Calcium Sensing Receptor in Health and Disease
por: Giudice, Maria Lo, et al.
Publicado: (2019) -
The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca(2+) channels
por: Greenberg, Harry Z.E., et al.
Publicado: (2016) -
Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells
por: Francistiová, Linda, et al.
Publicado: (2022) -
Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin-angiotensin system
por: Zhao, Yongli, et al.
Publicado: (2020)